Doliver Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,932
Closed -$476K 174
2021
Q4
$476K Sell
1,932
-147
-7% -$32.3K 0.15% 96
2021
Q3
$402K Buy
2,079
+16
+0.8% +$3.24K 0.14% 117
2021
Q2
$439K Sell
2,063
-362
-15% -$76.4K 0.15% 94
2021
Q1
$495K Sell
2,425
-585
-19% -$115K 0.18% 86
2020
Q4
$548K Buy
3,010
+505
+20% +$85.9K 0.24% 69
2020
Q3
$419K Buy
2,505
+760
+44% +$128K 0.21% 83
2020
Q2
$284K Sell
1,745
-2,882
-62% -$517K 0.13% 105
2020
Q1
$869K Buy
4,627
+70
+2% +$13.9K 0.43% 38
2019
Q4
$915K Sell
4,557
-83
-2% -$17K 0.36% 37
2019
Q3
$986K Buy
4,640
+240
+5% +$50.1K 0.4% 37
2019
Q2
$854K Buy
4,400
+698
+19% +$129K 0.34% 33
2019
Q1
$609K Buy
3,702
+1,189
+47% +$210K 0.25% 41
2018
Q4
$473K Buy
+2,513
New +$464K 0.23% 61

Other funds holding CME

Doliver Advisors's CME Position: Q1 2022 in Review

Doliver Advisors sold out of CME Group (CME) in Q1 2022, closing a stake of 1,932 shares — an estimated $476K sold.

Doliver Advisors first reported a position in CME in Q4 2018 and held it in 13 quarters. The position peaked at $986K in Q3 2019. 1,183 funds tracked by Wall St. Rank hold CME as of Q1 2022.

  • Doliver Advisors reported no remaining CME Group position as of Q1 2022 after selling out during the quarter.
  • Doliver Advisors sold 1,932 CME Group shares in Q1 2022, an estimated $476K.
  • Doliver Advisors first reported a position in CME Group in Q4 2018 and held it in 13 quarters.
  • Doliver Advisors's CME Group position peaked at $986K in Q3 2019.
  • 1,183 funds tracked by Wall St. Rank held CME Group as of Q1 2022.

Based on Doliver Advisors's 13F filing for Q1 2022, filed 9 May 2022.